Introduction
During the last decade, diagnostic use of radiation has dramatically increased by as much as 2-to 3-fold in many countries. Despite the clear benefits of diagnostic radiation, the potential for increased cancer risk, particularly in children, is alarming (1) (2) (3) (4) (5) . International and domestic regulatory organizations for radiation protection recommend the use of the so-called 'linear no-threshold' model (6, 7) , in which cancer risk from low doses (,100 mSv) is extrapolated from the risk from moderate to high doses using the hypothesis of a linear dose-response relationship. Epidemiological studies indeed provide evidence for increased cancer risk at low doses (8) (9) (10) (11) (12) . However, whether cancer risk following low doses fits the linear no-threshold model is still controversial. A mechanistic understanding of carcinogenesis induced by low-dose radiation is required for accurate estimation of cancer risk following exposure to low doses (13) .
There is considerable variation in radiation-induced cancer susceptibility among humans, and genetic susceptibility to spontaneous tumors is accompanied by a greater-than-normal risk after radiation (14) . Cancer-prone subpopulations include those who have genetic defects in DNA repair or developmental signaling pathways, such as the Hedgehog and Wnt pathways (15) . Inherited inactivation of Ptch1, the sonic hedgehog (Shh) receptor and a negative regulator of the pathway (16, 17) , predisposes humans to childhood tumors such as medulloblastoma (MB) and rhabdomyosarcoma, as well as adult tumors such as basal cell carcinoma, also known as Gorlin syndrome (18) . Gorlin syndrome patients are sensitive to the carcinogenic effect of radiation (19) . The Ptch1 heterozygous mouse is an established model of human Gorlin syndrome (20, 21) . Pazzaglia et al. (22, 23) reported important findings for risk assessment of MB using Ptch1 þ/À mice. They showed a significant effect of intermediate doses of radiation (250 and 500 mGy), with an increase in MB incidence and a shortening of mean survival time in Ptch1 þ/À mice on the CD1 background (22) . Furthermore, they revealed that distinct chromosomal inactivation mechanisms were responsible for Ptch1 loss in spontaneous versus high-dose radiation-induced MB (23) .
To elucidate the cancer risk following low-dose radiation at ,100 mGy, we irradiated newborn C3B6F1 Ptch1 þ/À mice and examined the dose dependency of MB induction and the underlying molecular mechanism. We show that MB incidence increased and latency shortened even with an exposure of 50 mGy, which is comparable with the dose received from a computed tomography scan. Consistent with a previous report (23) , we found that radiation-induced tumors can be clearly distinguished from spontaneous tumors by the mode of loss of wild-type Ptch1. Radiation-associated Ptch1 loss was mediated by interstitial deletion, and spontaneous loss was mediated by mitotic recombination or non-disjunction with a subsequent duplication. Radiation-induced Ptch1 deletion increased in a dose-dependent manner, thus indicating that Ptch1 deletion is a useful radiation signature for evaluating the effects of low-dose radiation on carcinogenesis. Furthermore, this genomic radiation signature enabled us to identify many genes whose expression differed significantly between tumors having or lacking the signature. Some of these genes were located on chromosome 13 (chr-13), and their expression levels faithfully reflected the signature-associated genomic copy number reduction. Other genes were located on other chromosomes and included genes involved in early development of cerebellar granule neuron precursors, an origin for Shh pathway-associated MB (24) . These findings further our understanding of the risk of carcinogenesis following low-dose radiation, including exposure from medical diagnostic tests given to patients genetically predisposed for cancer; our results also suggest underlying mechanisms for radiation-induced carcinogenesis. 6 and 7 in 129S2 ES cells (21) , were obtained from the European Mouse Mutant Archive (http://www.emmanet.org/), where they had been backcrossed to C57BL/6 mice for three generations. They were then bred for four generations to C57BL/6JCrl mice in our laboratory. F1 hybrid mice generated by crossing C3H/He females and C57BL/6
Ptch1þ/À males (the latter obtained from in vitro fertilized embryos) were assigned to eight groups: non-irradiated controls and seven dose groups for X-ray irradiation. All animal experiments were conducted according to legal regulations in Japan and were carried out with permission and under regulation of the Institutional Animal Care and Use Committee of National Institute of Radiological Sciences.
X-ray irradiation Ptch1
þ/À mice and wild-type littermates were irradiated at postnatal day (PN) 1 at dose rates of $0.65 Gy/min (for total doses .0.1 Gy) or $0.10 Gy/min (for total doses 0.1 Gy). Irradiation was performed using a Pantak HF-320 X-ray generator (Pantak Ltd, East Haven, CT).
Tissue preparation Ptch1
þ/À mice were observed daily until moribund (i.e. marked emaciation, ruffling of fur or inactivity) and then were euthanized by venesection under ether anesthesia. Ptch1 þ/À mice that were still alive at the end of the observation period (PN250) were also euthanized. Portions of cerebellar tumors and normal tissue (ear and tail) were snap frozen in liquid nitrogen. The remaining whole brains were fixed with 10% neutral-buffered formalin. These specimens were embedded in paraffin to prepare coronal or sagittal sections, which were stained with hematoxylin and eosin.
Extraction of genomic DNA and total RNA For loss of heterozygosity (LOH) analysis, genomic DNA was isolated from MBs and ear samples using the Maxwell 16 Instrument and System (Promega, Madison, WI). For microarray analyses, genomic DNA and total RNA were purified using an AllPrep DNA/RNA Mini Kit (Qiagen, Valencia, CA) and Trizol Reagent (Invitrogen, Carlsbad, CA). Briefly, samples were homogenized in Buffer RLT plus buffer included in the kit, and genomic DNA was isolated using an AllPrep DNA spin column followed by RNase treatment. To prepare RNA samples, the homogenates were diluted 10-fold with Trizol Reagent, and total RNA was subsequently purified. The quality of total RNA was assessed using the QIAxcel system (Qiagen).
LOH analysis
Genomic DNA was amplified by polymerase chain reaction (PCR) using the following polymorphic markers: D13Mit303, D13Mit91, D13Mit210, D13Mit159, D13Mit76 and D13Mit35. PCR products were resolved with the capillary electrophoretic system HDA-GT12 Genetic analyzer with a Gel Cartridge Kit GSK-5000F (eGene, Irvine, CA). LOH analysis at the Ptch1 locus was also performed according to Pazzaglia et al. (23) by determining the sequence of exon 23, which includes a T/C polymorphism at position 4016 of the Ptch1 locus. All LOH analyses were performed on genomic DNAs from tumors and corresponding genomic DNAs from normal ear tissue as a control.
Array-based comparative genomic hybridization analysis We designed and used Agilent 8 Â 15 K-formatted and 4 Â 44 K-formatted mouse custom array-based comparative genomic hybridization (array-CGH) microarrays. Oligonucleotide probes in these custom microarrays distributed unevenly across the murine genome, with relatively higher densities in regions of interest including the region around Ptch1. Fluorescent labeling of DNA, microarray hybridization and post-hybridization washing were carried out according to the manufacturer's protocol (version 5) for oligonucleotide array-CGH for genomic DNA analysis (Agilent Technologies, Santa Clara, CA). Scanning was performed using an Agilent microarray scanner (G2565BA; Agilent Technologies). Signal intensities were measured with Feature Extraction software v9-5-1 and were evaluated using DNA analytics software v4-0-81 (Agilent Technologies).
Expression microarray analysis
For each analysis, 800 ng of total RNA was amplified and labeled with Cyanine 3 using Agilent's Low RNA Input Linear Amplification Kit (Agilent Technologies) following the manufacturer's protocol (version 5.5). Hybridization was performed on Whole Mouse Genome oligonucleotide microarrays (Agilent G4122F) using reagents and protocols provided by the manufacturer. Microarray data were analyzed using GeneSpring GX 10.0.2 (Agilent Technologies). Expression data were normalized both 'per chip' to the 75th percentile of all measurements in that sample and 'per gene' to the median expression levels of the gene across all samples except otherwise indicated. To remove probes with unreliable expression measurements, probes were filtered based on their signal intensity values and flag values. One-way analysis of variance was performed using Benjamini and Hochberg's false discovery rate as the multiple testing correction, with a P-value cut-off of 0.05. The microarray data reported in this article have been deposited in the Gene Expression Omnibus database at www.ncbi.nlm.nih.gov/geo (accession no. GSE19384). Affymetrix GeneChip microarray data on expression profiles of the developing cerebellum during PN days 1-21, which were part of data deposited in the Gene Expression Omnibus database by Kho et al. (accession no. GSE14514), were utilized by importing Affymetrix CEL files into GeneSpring GX 10.0.2. Data were processed with the summarization algorithm of Robust Multichip Analysis, and the baseline was transformed with respect the median of all samples.
Quantitative reverse transcription-PCR analysis
First strand complementary DNA was synthesized from 2 lg of total RNA using ReverTra Ace (Toyobo, Tokyo, Japan). The quantitative PCR reaction was performed on an Mx3000P real-time PCR system (Agilent Technologies) by using Premix Ex Taq (Takara Bio, Shiga, Japan) for the expression of a housekeeping gene, Gapdh, and by using SYBR Premix Ex Taq (Takara Bio) for the expression of Plagl1 and Tgfb2. The primer sequences used are listed in supplementary Table I , available at Carcinogenesis Online. The PCR program consisted of denaturation at 95°C for 10 s and 45 subsequent amplification cycles of denaturation at 95°C for 5 s and annealing/elongation at 60°C for 20 s. Relative gene expression was calculated by the 2 ÀDDC T method (25) .
Statistical analysis
To assess the dose-dependent effects of radiation on the incidence of MB, we used a Cox proportional hazard model to compute hazard ratios of each dose group relative to the non-irradiated group. We also assessed the linear increase in incidence according to the dose. We compared survival time between mice with S-type and R-type tumors by a Cox regression model, and the results were presented in terms of the hazard ratio. To adjust for radiation dose, this analysis was stratified by dose groups. In addition, we compared the proportion of R-type tumors between non-irradiated and 50 mGy irradiated groups with a MantelHaenszel test, which was stratified by gender. These analyses were performed using SAS version 9.2 (SAS Institute, Cary, NC).
Results

Dose-dependent increase of MB incidence in Ptch1 heterozygous mice following irradiation
To examine dose-dependent effects of radiation on MB development, we irradiated Ptch1 þ/À mice on the C3B6F1 background at PN1, when mice are most susceptible to the carcinogenic actions of ionizing radiation (IR) (22) , and followed their survival until 250 days of age. As shown in supplementary Table II, available at Carcinogenesis Online, we found that Ptch1 þ/À mice showed a high incidence of spontaneous MB (34.5% at 250 days of age). The effects of radiation were observed even in mice exposed to low doses of 50 and 100 mGy ( Figure 1 ; supplementary Table II is available at Carcinogenesis Online). There was a significant dose-dependent increase in the incidence rate of MB (P , 0.0001), indicating a dose-dependent shortening of the latent period. The mean survival time of mice that died due to MB before 250 days of age was shortened with increasing radiation doses (supplementary Table II is available at Carcinogenesis Online). Although the increase in the rate of MB was not statistically significant in mice receiving the lowest dose (50 mGy) compared with non-irradiated mice, the rate was significantly higher in mice exposed to higher doses (supplementary Table III is available at Carcinogenesis Online).
Dose-dependent increase of interstitial allelic losses of the genomic region around Ptch1 Pazzaglia et al. (23) suggested that the pattern of LOH on chr-13 in six radiation-induced (3 Gy) MBs may be distinguished from that in four spontaneous MBs that developed in Ptch1 þ/À mice. We thus examined patterns of chr-13 LOH in all tumors for which both tumor and normal ear DNAs were available using six microsatellite markers (Figure 2 ; supplementary Figure 1A is available at Carcinogenesis Online). We observed that 146 of 163 (90%) MBs showed loss of the C3H-derived wild-type allele at one or more of the six markers. These 146 tumors were grouped into two types: S-type tumors showed LOH in broad regions on chr-13, with losses at all consecutive markers distal to Ptch1 locus, and R-type tumors showed interstitial losses around the Ptch1 locus with distal markers retained. We then Radiation signatures in medulloblastomas in Ptch1 +/-mice examined whether the remaining 17 MBs showed LOH at the Ptch1 locus by exploiting a T/C polymorphism at position 4016 of Ptch1 (23). Of these MBs, 14 showed loss of the wild-type C3H allele (supplementary Figure 1B is available at Carcinogenesis Online). The remaining three tumors were further analyzed by array-CGH, which revealed that one MB had an intragenic microdeletion ($7.9 kb) in the region slightly more telomeric to the above-mentioned T/C polymorphism (supplementary Figure 1C and D is available at Carcinogenesis Online). We did not detect a loss of the wild-type Ptch1 allele in the remaining two MBs. This microdeletion and the abovementioned 14 tumors were classified as R-type. Thus, we identified aberrations on chr-13 in 161 of 163 (99%) tumors analyzed, a result that is consistent with Knudson's two-hit theory (26, 27) . Notably, all 19 spontaneous MBs were classified as S-type, whereas all 19 MBs induced after 3 Gy irradiation had R-type LOH patterns (Table I) . The incidence of R-type tumors was dose dependent and, importantly, R-type tumors were found even in mice exposed to the lowest radiation dose (50 mGy; Figure 3A and B). These data strongly demonstrated that an R-type LOH pattern can be considered a reliable radiation signature. The proportion of R-type patterns was significantly different in mice exposed to the lowest dose (50 mGy) compared with nonirradiated mice (P 5 0.0071, Mantel-Haenszel test). We also noticed that the distribution of survival time of R-type MBs (red diamonds in Figure 3A ) appeared to be shifted downwardly compared with that of S-type MBs (light blue diamonds in Figure 3A) , suggesting that R-type MBs had relatively shorter latent periods as a whole. Statistical analysis indicated that R-type MBs had greater risk of death than S-type MBs (hazard ratio, 1.64; 95% confidence interval 1.05-2.57). In association with this, we analyzed whether there were histological differences between S-type and R-type MBs, as well as those between MBs with short and long latencies. Although focal areas of tumors occasionally showed desmoplastic reaction in some cases, majority of MBs showed anaplastic cells or monomorphic round cells, and no clear differences which were associated either with the type of LOH (S-or R-type) or length of latency were observed.
Interstitial chr-13 deletions in MBs revealed by array-CGH analysis
To characterize S-type and R-type tumors in more detail, we performed array-CGH analysis on 12 tumors. S-type tumors were selected from tumors that developed in non-irradiated control mice or mice exposed to 0.2 Gy irradiation, and R-type tumors were selected from mice that received 0.2 or 1.5 Gy irradiation (three per group; supplementary Table IV is available at Carcinogenesis Online and Figure 4A ). Array-CGH analysis revealed a copy number reduction at a small region within Ptch1, which included exons 6 and 7, in all 12 MBs analyzed ( Figure 4A ). Because the genomic region containing exons 6 and 7 was replaced with a neomycin resistance cassette (21), loss of this region indicated a loss of the maternal wild-type C3H allele of Ptch1. Although all S-type MBs showed normal copy numbers in other regions throughout chr-13 independent of LOH status, R-type MBs showed a 2-fold reduction in copy number in all interstitial regions exhibiting loss of the C3H allele ( Figure 4A ). These data suggest that S-type LOH patterns resulted from a mitotic recombination or a non-disjunction with a subsequent duplication, whereas R-type patterns may have resulted from interstitial deletion.
Strong association between gene expression and genomic copy number aberrations We next carried out microarray gene expression analysis on the same 12 MBs to examine how expression profiles differed among MBs in connection with the dose of radiation and mode of Ptch1 loss. Gene expression patterns in normal cerebellum at comparable ages (103-113 days after birth) were also analyzed for reference (supplementary Table IV is available at Carcinogenesis Online). Using principal component analysis, we observed that the six R-type MBs formed a readily discernible assembly ( Figure 4B ), suggesting that R-type MBs were highly similar with respect to gene expression. To identify genes whose expression was significantly different between groups, we performed one-way analysis of variance with Tukey's post-hoc test. This analysis identified 1183 genes (1297 probes) whose expression differed between the four groups. The result of the Tukey's post-hoc test indicated that the majority of the genes were differentially expressed between S-type and R-type MBs (supplementary Table V is available at Carcinogenesis Online). Among them, 95 genes (141 probes) were located within the common deleted region around the Ptch1 locus on chr-13 in the six R-type MBs. Most of the genes revealed expression that was reduced almost by half in R-type MBs, suggesting that the expression faithfully reflected copy Another case with a small intragenic deletion within the Ptch1 locus was also included in this type. N: two tumors that showed neither LOH nor copy number reduction on chr-13.
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number reduction. Figure 4C shows expression levels revealed by 1188 probes (818 genes), which were mapped on chr-13. The light blue regions, which are rich in genes with decreased expression, coincided accurately with the deleted regions shown in Figure 4A . Of note, the expression level of Ptch1 was also decreased by copy number reduction ( Figure 5A ). Although the expression of Shh in all tumors was below measurable levels, three other hedgehog targets and mediator genes (Ptch2, Gli1 and Gli2) were upregulated to a similar extent in all tumors ( Figure 5B-D) , perhaps reflecting constitutive activation of the Hedgehog/Patched signaling pathway due to inactivation of both Ptch1 alleles.
Association between the radiation signature and early-PN development of the cerebellum The mode of Ptch1 loss also significantly affected hundreds of genes located on chromosomes other than chr-13. Comparison of genes found to be differentially expressed between groups based on Tukey's post-hoc test (supplementary Table V is available at Carcinogenesis Online) revealed that 573 genes (664 probes) located on chromosomes other than chr-13 showed differential expression in all cases of comparison between groups of S-type and R-type tumors. Interestingly, these genes included Plagl1/Zac1 and Tgfb2, which are reported to be strongly expressed transiently during early development of cerebellar granule cell (28, 29) . The quantitative reverse transcription-PCR analysis on the expression of Plagl1/Zac1 and Tgfb2 validated the microarray data; transcriptional level of Plagl1/Zac1 was much higher in R-type than S-type, whereas that of Tgfb2 was higher in S-type than R-type ( Figure 5E and F) . The statistical significance of their different expression levels between S-type and R-type MBs was still maintained after the data of additional six S-type and nine R-type MBs (supplementary Table IV is available at Carcinogenesis Online) were included for analysis. Because the peak expression of Plagl1/Zac1 (28) occurs at earlier developmental stages than that of Tgfb2 (29), global gene expression of R-type MBs might be associated with earlier developmental stages of cerebellum. It is of note that global gene expression within individual MBs reflects particular stages of cerebellar development (30) . Next, we examined whether there was an association between the 573 differentially expressed genes and certain stages of the developing cerebellum. These 573 genes were subdivided into two groups based on whether they were expressed higher in R-type or S-type tumors (supplementary Figure 2A and B is available at Carcinogenesis Online). Based on microarray data on the expression profiles of the developing cerebellum during PN1-PN21 [as deposited in the Gene Expression Omnibus database by Kho et al. (30) ], we selected genes that were included in that database and whose expression changed .1.5-fold or 2-fold during PN1-PN21. The histograms in supplementary Figure 2C and D (available at Carcinogenesis Online) represent the number of probe sets as a function of the day when the intensity of the probe set was maximal. Many genes whose expression was higher in R-type tumors showed maximum expression at PN1-PN5 (supplementary Figure 2C is available at Carcinogenesis Online), suggesting an association between the radiation signature and the early stages of PN cerebellar development.
Association between frequent aneuploidy of chromosome 6 and gene expression Besides deletions on chr-13, aneuploidies of chromosome 6 (chr-6) and the X chromosome were prominent aberrations (supplementary Table VI is available at Carcinogenesis Online). The correlation between expression levels of genes on chr-6 and their genomic dosage was examined (supplementary Figure 3 is available at Carcinogenesis Online). It was found that expression levels of many genes on chr-6 reflected aneuploidy of chr-6. Among 2161 probes (1494 genes) on chr-6 analyzed, 835 probes (534 genes) revealed increased expression as a function of genomic dosage of chr-6 (Pearson correlation coefficient . 0.5). Supplementary Figure 3C (available at Carcinogenesis Online) shows the correlation of the 10 genes with the highest coefficients, together with that of FoxM1 (0.90) and Ccnd2 (0.76), which were suggested as potential candidate genes on chr-6 that contribute to tumorigenesis of MB in relationship with trisomy 6 (31) or partial amplification of chr-6 (32). Fig. 3 . Relationship between survival of individual tumor-bearing mice and chr-13 LOH pattern. (A) Light blue and red diamonds represent mice with S-type and R-type tumors, respectively. Two black circles at doses of 0.1 and 1.5 Gy correspond to tumors that showed neither LOH nor copy number reduction on chr-13. Crosses indicate mice whose MB DNAs could not be used for LOH analysis. (B) Dose-effect relationships of the incidence of S-type (light blue diamonds) and R-type (red diamonds) tumors. Some tumors could not be examined for LOH analysis due to the absence of frozen tumor samples. Therefore, we calculated the incidence of S-type and R-type tumors by multiplying the total MB incidence at each dose by the rate of both tumor types, of which LOH could be determined. The shape of the dose-response curve of R-type tumor incidence is downwardly concave in the 0-3 Gy dose range, and the linear relationship is not rejected when the goodness of fit is assessed in the 0-0.2 Gy dose range by the chi-square test (P 5 0.13). Radiation signatures in medulloblastomas in Ptch1 +/-mice Discussion Radiation signatures, either genomic aberrations or gene expression profiles, that distinguish radiation-induced tumors from spontaneous tumors would be very useful for not only assessing cancer risk following low-dose radiation but also understanding the underlying mechanisms of carcinogenesis. Much effort has been made toward identifying such radiation signatures in a variety of tumors. A few studies have successfully identified genomic fingerprints of IR in human (33) and mouse (34-37) tumors. For example, LOH at PTCH1 is more frequent in tumors from high-dose IR-exposed (!1 Gy) atomic bomb survivors than in those from low-dose IR-exposed (,0.2 Gy) survivors (38) . However, it has not yet been reported whether LOH can be practically applied for distinguishing spontaneous tumors from those induced by low-dose radiation. Based on LOH patterns in 10 MBs, Pazzaglia et al. (23) suggested that distinct mechanisms are responsible for Ptch1 loss in spontaneous versus radiation-induced MBs. Consistently, we confirmed that deletion-mediated loss of the wild-type Ptch1 allele (R-type) can be considered a reliable radiation signature for radiation-induced MBs in Ptch1 þ/À mice. These data are in line with the previous reports supporting the notion that IR tends to cause interstitial deletions. The strictness in the association of deletion-mediated loss with radiationinduced MB in Ptch1 heterozygous mice is a significant point to be emphasized. The difference in the frequency of interstitial losses between spontaneous and radiation-induced mutations was a matter of degree in the previous reports, such as those on hprt (hypoxanthin guanine phosphoribosyl transferase), aprt (adenine phosphoribosyltransferase) and Apc (adenomatous polyposis coli) loci (34, 39, 40) . How interstitial loss predominates in radiation-induced tumors would depend on various factors, such as the critical gene included in the region, genetic background and allelic status of the gene (41) (42) (43) . In addition, it should be mentioned that deletion-mediated loss is one of . In this analysis, expression levels in two normal cerebellum samples (N1 and N3) were not examined, whereas expression levels in developing cerebellum samples (PN5-1 and PN5-2) at PN5 were analyzed. Box and whisker summary plots at the right in (E) and (F) show expression levels of 12 S-type MBs (6 MBs analyzed by expression microarray analysis and additional 6 MBs) and those of 15 R-type MBs (6 MBs analyzed by expression microarray analysis and additional 9 MBs). Twelve of these additional 15 MBs (Tumor numbers are 16-30  in supplementary Table IV , available at Carcinogenesis Online) were selected from experimental groups with low-dose irradiation. Paired boxes represent the 25th-75th percentile expression values in S-type and R-type MBs. Horizontal bars indicate median, whereas vertical lines indicate maximum and minimum expression values.
Radiation signatures in medulloblastomas in Ptch1
+/-mice the relevant mechanisms responsible for the inactivation of tumor suppressor genes in spontaneous tumors and that many reports have demonstrated the involvement of multiple mechanisms in inactivating tumor suppressor genes in radiation-induced tumors (44, 45) . In the present study, while deletion-mediated loss was perfectly associated with radiation-induced MBs from mice exposed to 3 Gy, no spontaneous-type (S-type) LOH patterns were detected in those tumors. Earlier development of R-type MBs may have prevented the appearance of S-type MBs. Alternatively, radiation may provide suppressive as well as inductive effects on spontaneous tumorigenesis. Indeed, it has been reported that early cerebellum lesions at 3 weeks of age were detected less frequently in mice exposed to 3 Gy at PN10 compared with non-irradiated control mice (46) . An important unresolved question in radiation protection is whether and how cancer risk increases dose dependently even at low doses ,100 mSv or if there exists a threshold dose for radiationinduced carcinogenesis (6) . Here, we have provided direct evidence of a dose-dependent increase in MBs harboring a radiation signature in Ptch1 þ/À mice exposed to doses at 0.05 Gy (50 mGy) to 3 Gy. The incidence of R-type tumors increased dose dependently even at low doses of 50 and 100 mGy (Figure 3) , suggesting that there is no discernable threshold dose, at least for genetically susceptible mice.
Importantly, our data also suggest that the cancer risk from lowdose radiation in individuals who share one crucial genetic risk factor may vary considerably depending on genetic background. We showed that Ptch1 þ/À mice on the C3B6F1 background were prone to the development of radiation-induced MBs, whose susceptibility was higher than those on the CD1 background (22) . In addition, Pazzaglia et al. have reported that Ptch1 þ/À mice on the C57BL/6 background are completely resistant. In connection with this resistance to radiation on the C57BL/6 background, we obtained array-CGH data showing the absence of interstitial deletions of the genomic region including Ptch1 locus in MBs developed spontaneously (n 5 3) and after 3 Gy irradiation at PN1 (n 5 4) in Ptch1 þ/À mice on this background (data not shown), suggesting the relationship between sensitivity to radiation and the genomic radiation signature. Understanding the genetic mechanisms by which genetic backgrounds influence cancer risk will lead to better radioprotection in the future.
We found that the expression levels of hundreds of genes were closely associated with the signature and that radiation-induced MBs appeared highly similar with regard to global gene expression patterns. By integrating the data from the array-CGH analysis, we found that many of these genes reflected a signature-associated reduction in copy number on chr-13. In a recent report, human MBs were grouped into five subtypes, one of which was characterized by Shh signaling (47) . Frequent deletions of the genomic region around the PTCH1 locus were identified in this subgroup. Interestingly, gene expression levels also faithfully reflected chromosomal copy number changes in those tumors, consistent with our current results.
Many genes located on chromosomes other than chr-13 also showed differential expression patterns between tumors having or lacking the radiation signature. Differential expression of these genes might simply be indirect consequences of changes in the expression of certain genes in the deleted region on chr-13. On the other hand, differential expression may reflect other important biological aspects of radiation-induced carcinogenesis. We found an association among expression levels of genes, type of LOH (S-or R-type) and developmental stages of the cerebellum (supplementary Figure 2C is available at Carcinogenesis Online). Those genes included, for instances, Plagl1/Zac1 and Tgfb2. Plagl1/Zac1, which was expressed higher in R-type MBs, is highly expressed in the external granular layer of the rat cerebellum, being maximal at PN5 through PN7 and then falling off thereafter (28) . In contrast, the expression level of Tgfb2, which was lower in R-type MBs, is low at early PN stages in the external granular layer but considerably high at relatively later stages around PN10 (29) . Together with the evidence that many other genes whose expression levels were significantly elevated in R-type tumors were also expressed maximally at early developmental stages (PN1-PN5) of the cerebellum, we hypothesized that R-type tumors had been initiated at earlier stages of cerebellar development compared with S-type tumors. This was in good agreement with that R-type tumors developed earlier than S-type ones. Earlier initiation could be one of the important causal factors for the earlier development, but another possible factor of higher proliferation rate also remains to be elucidated.
In conclusion, we present for the first time evidence that MBs in newborn Ptch1 þ/À mice induced by radiation, even at low doses comparable with those used for medical diagnostics, can be distinguished from spontaneous MBs not only by the interstitial deletion of the Ptch1 locus but also by gene expression profiles partly associated with unique developmental stages.
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